Sign in
CompletedPhase 3

IV Lidocaine Analgesia in Pediatric Scoliosis Surgery

Key facts

Who runs it
University of British Columbia
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
48 people enrolled
Started
18 Dec 2019
Ended
10 May 2024
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Lidocaine
  • Saline Solution
Record updated
14 May 2024

Who can take part

Age
10 years to 19 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • ASA I-III
  • Diagnosed with Idiopathic scoliosis
  • Undergoing single-stage posterior spinal instrumentation and fusion

Who cannot take part

  • Pre-existing pain complaints, i.e. on regular analgesic medications
  • Known allergy to lidocaine
  • Known cardiac, renal or liver disease or dysfunction
  • Current psychiatric diagnosis, e.g. anxiety, depression, eating disorder, defined according to DSM criteria
  • Any history of seizures
  • Weight < 5th centile or > 85th centile for age
  • Thorascopic tethering procedure
  • Two-stage procedure
  • Abnormal developmental profile
  • Congenital/neuromuscular scoliosis
  • Requiring PICU admission
  • Requiring non-standard post-op pain management
  • Unplanned staged procedure
  • Porphyria

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Surgical correction of scoliosis in children is a long procedure, with an equivalently long recovery time, that is commonly performed at BC Children's Hospital. Treating pain immediately after the procedure is a priority for children during recovery. Morphine is one medication that can be used to manage post-operative pain, but unfortunately, its use is accompanied by a number of side effects which can affect recovery. These include nausea, vomiting, pruritus, sedation, dysphoria, respiratory depression, constipation, ileus, and urinary retention.

Read full original descriptionShow less

In order to control pain and reduce morphine consumption, intravenous lidocaine is being investigated. This therapy has been beneficial in adult populations undergoing abdominal surgery and has been associated with decreased post-operative pain, decrease use of opioids including morphine, and ileus. These all contribute to shorter lengths of stay in the hospital and better recovery in the adult population.

Intravenous lidocaine is used by some anesthesiologists at BC Children's Hospital to manage post-operative pain in children receiving surgical correction for scoliosis, but this is not a standard of practice. We now propose to conduct a double-blind randomized controlled trial to determine if intravenous lidocaine, infused from start of anesthesia up to 48 hours post-operatively, will reduce morphine use and improve post-operative pain in the pediatric population.

The 2 groups in the trial

  • Intravenous lidocaineTreatment being tested

    1% preservative free lidocaine 10 mg/ml in 0.9% NaCl

    Treatment: Lidocaine

  • Intravenous saline controlPlacebo, for comparison

    0.9% sodium chloride, also known as normal saline

    Treatment: Saline Solution

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Perioperative Multimodal Analgesia Including Intravenous Lidocaine Infusion for Pain Management Following Idiopathic Scoliosis Correction Surgery in Children
Publications
Record updated
14 May 2024